DE69841994D1 - 32 Humane sekretierte Proteine - Google Patents

32 Humane sekretierte Proteine

Info

Publication number
DE69841994D1
DE69841994D1 DE69841994T DE69841994T DE69841994D1 DE 69841994 D1 DE69841994 D1 DE 69841994D1 DE 69841994 T DE69841994 T DE 69841994T DE 69841994 T DE69841994 T DE 69841994T DE 69841994 D1 DE69841994 D1 DE 69841994D1
Authority
DE
Germany
Prior art keywords
secreted proteins
human secreted
proteins
novel human
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841994T
Other languages
English (en)
Inventor
Steven M Ruben
Craig A Rosen
Kenneth C Carter
Patrick J Dillon
Gregory A Endress
Guo-Liang Yu
Jian Ni
Ping Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of DE69841994D1 publication Critical patent/DE69841994D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69841994T 1997-05-30 1998-05-28 32 Humane sekretierte Proteine Expired - Lifetime DE69841994D1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US4809397P 1997-05-30 1997-05-30
US4819097P 1997-05-30 1997-05-30
US4810197P 1997-05-30 1997-05-30
US4835697P 1997-05-30 1997-05-30
US5093597P 1997-05-30 1997-05-30
US4403997P 1997-05-30 1997-05-30
US5629397P 1997-08-29 1997-08-29
US5625097P 1997-08-29 1997-08-29
US5629697P 1997-08-29 1997-08-29
PCT/US1998/010868 WO1998054206A1 (en) 1997-05-30 1998-05-28 32 human secreted proteins

Publications (1)

Publication Number Publication Date
DE69841994D1 true DE69841994D1 (de) 2010-12-23

Family

ID=27578175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841994T Expired - Lifetime DE69841994D1 (de) 1997-05-30 1998-05-28 32 Humane sekretierte Proteine

Country Status (11)

Country Link
US (4) US6531447B1 (de)
EP (2) EP2332975A1 (de)
JP (1) JP2002512521A (de)
AT (1) ATE487737T1 (de)
AU (1) AU7801998A (de)
CA (1) CA2291221A1 (de)
CY (1) CY1111950T1 (de)
DE (1) DE69841994D1 (de)
DK (1) DK1015477T3 (de)
PT (1) PT1015477E (de)
WO (1) WO1998054206A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129061B1 (en) * 1996-08-07 2006-10-31 Biogen Idec Ma Inc. Tumor necrosis factor related ligand
EP0837128A3 (de) * 1996-10-21 1999-04-28 Smithkline Beecham Corporation Menschlicher G-Protein gekoppelter Rezeptor, HLYAZ61
WO2001032674A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 26 human secreted proteins
WO2000047602A1 (en) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 human secreted proteins
WO1998054206A1 (en) 1997-05-30 1998-12-03 Human Genome Sciences, Inc. 32 human secreted proteins
TW546381B (en) * 1997-04-18 2003-08-11 Chugai Pharmaceutical Co Ltd Transcriptional regulator containing a bromo-domain
US7001992B2 (en) 1997-05-30 2006-02-21 Human Genome Sciences, Inc. Antibodies to secreted protein HEMCM42
WO2000011942A1 (en) * 1998-09-01 2000-03-09 Gene Logic, Inc. IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE
US6372490B1 (en) * 1999-02-23 2002-04-16 Curagen Corporation Nucleic acid encoding the MDM interacting protein
FR2797447B1 (fr) * 1999-08-12 2004-04-02 Univ Clermont Auvergne "odorant-binding" proteines humaines fixant des ligands hydrophobes:polypeptides et polynucleotides codant lesdits polypeptides et leurs applications
AU1438201A (en) * 1999-10-29 2001-05-14 Human Genome Sciences, Inc. 25 human secreted proteins
CA2394015C (en) 1999-12-20 2013-11-05 Immunex Corporation Tweak receptor
US6727225B2 (en) 1999-12-20 2004-04-27 Immunex Corporation TWEAK receptor
EP1174502A1 (de) * 2000-07-18 2002-01-23 Schering Corporation Kodierende Nukleinsäuren aus Vorläufern von Typ 2 dendritischen Zellen und damit zusammenhängende Zusammensetzungen und Verfahren
JP4319979B2 (ja) 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド タンパク質の非アフィニティ精製
WO2005010045A1 (en) 2003-07-24 2005-02-03 Amgen Inc. Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor
EP2332408B1 (de) 2005-02-17 2013-11-13 Biogen Idec MA Inc. Behandlung neurologischer Störungen
ES2432564T3 (es) 2005-05-10 2013-12-04 Biogen Idec Ma Inc. Tratamiento y evaluación de trastornos inflamatorios
EP1876448A1 (de) * 2005-09-30 2008-01-09 DIGILAB BioVisioN GmbH Verfahren und analytische Reagenzien zur Medikamentidentifizierung mittels auf Thiazolidinedionen reagierenden Biomarkern
EP2565204B1 (de) 2007-07-27 2015-10-07 immatics biotechnologies GmbH Neuartige immunogenetische Epitope zur Immuntherapie
EP2545938A1 (de) 2007-08-03 2013-01-16 Abbott Biotherapeutics Corp. Therapeutische Verwendung von Anti-TWEAK-Rezeptorantikörpern
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US912292A (en) * 1907-05-03 1909-02-16 Morris E Curtis Machine for making tubes.
US912293A (en) * 1908-02-03 1909-02-16 Nat Regulator Company Temperature-regulating device.
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
JPS58118008A (ja) 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
EP0088046B1 (de) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
EP0142641B1 (de) 1983-09-26 1991-01-16 Udo Dr. Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
EP0143949B1 (de) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmazeutische Zusammensetzung mit Gehalt an Urokinase
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
EP0232262A4 (de) 1985-08-15 1989-09-19 Stauffer Chemical Co Tryptophan erzeugender mikroorganismus.
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US5128256A (en) 1987-01-12 1992-07-07 Stratagene DNA cloning vectors with in vivo excisable plasmids
EP0394827A1 (de) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide
ES2120949T4 (es) 1990-06-28 2011-12-29 Sanofi-Aventis Deutschland Gmbh 50% Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo.
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
KR19990008335A (ko) 1995-05-05 1999-01-25 로버트 에리치. 벤슨 인체 케모킨 베타-8, 케모킨 베타-1 및 대식세포 염증 단백질-4
FR2741075B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant
CA2280231A1 (en) 1997-02-12 1998-08-13 Abbott Laboratories Member of the tnf family useful for treatment and diagnosis of disease
WO1998054206A1 (en) * 1997-05-30 1998-12-03 Human Genome Sciences, Inc. 32 human secreted proteins
AU7549498A (en) * 1997-06-03 1998-12-21 Protegene Inc. Human proteins having transmembrane domains and dnas encoding these prot eins
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
AU4409099A (en) 1998-05-29 1999-12-13 Incyte Pharmaceuticals, Inc. Human transmembrane proteins
CA2394015C (en) * 1999-12-20 2013-11-05 Immunex Corporation Tweak receptor

Also Published As

Publication number Publication date
EP2332975A1 (de) 2011-06-15
EP1015477B1 (de) 2010-11-10
DK1015477T3 (da) 2011-02-07
US20060147982A1 (en) 2006-07-06
US20030195346A1 (en) 2003-10-16
AU7801998A (en) 1998-12-30
CY1111950T1 (el) 2015-11-04
CA2291221A1 (en) 1998-12-03
PT1015477E (pt) 2010-12-28
US20070248593A1 (en) 2007-10-25
WO1998054206A1 (en) 1998-12-03
EP1015477A1 (de) 2000-07-05
ATE487737T1 (de) 2010-11-15
US6531447B1 (en) 2003-03-11
EP1015477A4 (de) 2004-05-26
JP2002512521A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
WO1998040483A3 (en) 28 human secreted proteins
EP1053245A4 (de) 45 menschliche sekretierte proteine
WO1998031800A3 (en) Human proteins
WO1998045712A3 (en) 20 human secreted proteins
WO2001036432A3 (en) 18 human secreted proteins
WO2001032910A3 (en) 27 human secreted proteins
WO2001012776A3 (en) 18 human secreted proteins
WO2001034768A3 (en) 15 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000077026A8 (en) 49 human secreted proteins
WO2000063230A3 (en) 49 human secreted proteins
EP1042342A4 (de) 53 proteine menschlichen ursprungs
WO2001062891A3 (en) 207 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
WO2001012775A3 (en) 25 human secreted proteins
WO2000061774A3 (en) Bone morphogenic proteins
WO2000043495A3 (en) 33 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
WO2000061596A8 (en) 50 human secreted proteins
WO2003052377A9 (en) 41 human secreted proteins
WO2002099066A3 (en) 20 human secreted proteins
WO2001034767A3 (en) 22 human secreted proteins